{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T08:09:02Z","timestamp":1758355742274,"version":"3.44.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,19]]},"DOI":"10.7759\/cureus.92701","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T11:31:29Z","timestamp":1758281489000},"source":"Crossref","is-referenced-by-count":0,"title":["Cocaine- and Levamisole-Induced Vasculitis (CLIV)"],"prefix":"10.7759","author":[{"given":"Zahra","family":"Vaezi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afshin","family":"Amini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-022-01088-0","article-title":"A spotlight on drug-induced vasculitis","volume":"24","author":"Yaseen K","year":"2022","unstructured":"Yaseen K, Nevares A, Tamaki H. A spotlight on drug-induced vasculitis. Curr Rheumatol Rep. 2022, 24:323-36. 10.1007\/s11926-022-01088-0","journal-title":"Curr Rheumatol Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13175116","article-title":"Cocaine- and levamisole-induced vasculitis: defining the spectrum of autoimmune manifestations","volume":"13","author":"Iorio L","year":"2024","unstructured":"Iorio L, Davanzo F, Cazzador D, et al.. Cocaine- and levamisole-induced vasculitis: defining the spectrum of autoimmune manifestations. J Clin Med. 2024, 13:5116. 10.3390\/jcm13175116","journal-title":"J Clin Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-017-0653-9","article-title":"Cocaine-levamisole-induced vasculitis\/vasculopathy syndrome","volume":"19","author":"Marquez J","year":"2017","unstructured":"Marquez J, Aguirre L, Mu\u00f1oz C, Echeverri A, Restrepo M, Pinto LF. Cocaine-levamisole-induced vasculitis\/vasculopathy syndrome. Curr Rheumatol Rep. 2017, 19:36. 10.1007\/s11926-017-0653-9","journal-title":"Curr Rheumatol Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5041\/RMMJ.10263","article-title":"Cocaine-induced vasculitis","volume":"7","author":"Berman M","year":"2016","unstructured":"Berman M, Paran D, Elkayam O. Cocaine-induced vasculitis. Rambam Maimonides Med J. 2016, 7:e0036. 10.5041\/RMMJ.10263","journal-title":"Rambam Maimonides Med J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-022-01217-1","article-title":"Cocaine-induced vasculitis and mimics of vasculitis (Article in German)","volume":"82","author":"Ruffer N","year":"2023","unstructured":"Ruffer N, Krusche M, Holl-Ulrich K, K\u00f6tter I, L\u00f6tscher F. Cocaine-induced vasculitis and mimics of vasculitis (Article in German). Z Rheumatol. 2023, 82:606-14. 10.1007\/s00393-022-01217-1","journal-title":"Z Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05790-9","article-title":"Mechanisms of thrombosis in ANCA-associated vasculitis","volume":"40","author":"Misra DP","year":"2021","unstructured":"Misra DP, Thomas KN, Gasparyan AY, Zimba O. Mechanisms of thrombosis in ANCA-associated vasculitis. Clin Rheumatol. 2021, 40:4807-15. 10.1007\/s10067-021-05790-9","journal-title":"Clin Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000766","article-title":"Cerebral vasculitis associated with drug abuse","volume":"33","author":"Younger DS","year":"2021","unstructured":"Younger DS. Cerebral vasculitis associated with drug abuse. Curr Opin Rheumatol. 2021, 33:24-33. 10.1097\/BOR.0000000000000766","journal-title":"Curr Opin Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.nic.2023.07.003","article-title":"Imaging of drug-related vasculopathy","volume":"34","author":"Puac-Polanco P","year":"2024","unstructured":"Puac-Polanco P, Rovira \u00c0, Shah LM, Wiggins RH, Rivas Rodriguez F, Torres C. Imaging of drug-related vasculopathy. Neuroimaging Clin N Am. 2024, 34:113-28. 10.1016\/j.nic.2023.07.003","journal-title":"Neuroimaging Clin N Am"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmr.2019.11.641","article-title":"Pulmonary complications in cocaine users (Article in French)","volume":"37","author":"Underner M","year":"2020","unstructured":"Underner M, Peiffer G, Perriot J, Jaafari N. Pulmonary complications in cocaine users (Article in French). Rev Mal Respir. 2020, 37:45-59. 10.1016\/j.rmr.2019.11.641","journal-title":"Rev Mal Respir"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-015-0545-9","article-title":"Drug-induced vasculitis: new insights and a changing lineup of suspects","volume":"17","author":"Grau RG","year":"2015","unstructured":"Grau RG. Drug-induced vasculitis: new insights and a changing lineup of suspects. Curr Rheumatol Rep. 2015, 17:71. 10.1007\/s11926-015-0545-9","journal-title":"Curr Rheumatol Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.11.011","article-title":"Cocaine and ANCA associated vasculitis-like syndromes - a case series","volume":"17","author":"Subesinghe S","year":"2018","unstructured":"Subesinghe S, van Leuven S, Yalakki L, Sangle S, D'Cruz D. Cocaine and ANCA associated vasculitis-like syndromes - a case series. Autoimmun Rev. 2018, 17:73-7. 10.1016\/j.autrev.2017.11.011","journal-title":"Autoimmun Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2014-0107-RS","article-title":"Levamisole-induced vasculitis: a characteristic cutaneous vasculitis associated with levamisole-adulterated cocaine","volume":"139","author":"Roberts JA","year":"2015","unstructured":"Roberts JA, Ch\u00e9vez-Barrios P. Levamisole-induced vasculitis: a characteristic cutaneous vasculitis associated with levamisole-adulterated cocaine. Arch Pathol Lab Med. 2015, 139:1058-61. 10.5858\/arpa.2014-0107-RS","journal-title":"Arch Pathol Lab Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/ph16060846","article-title":"Pulmonary-renal syndrome from levamisole-adulterated cocaine-induced antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis: a systematic review","volume":"16","author":"Bucur P","year":"2023","unstructured":"Bucur P, Weber M, Agrawal R, Madera-Acosta AI, Elam RE. Pulmonary-renal syndrome from levamisole-adulterated cocaine-induced antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis: a systematic review. Pharmaceuticals (Basel). 2023, 16:846. 10.3390\/ph16060846","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-019-04410-9","article-title":"Cocaine-induced ANCA-associated renal disease: a case-based review","volume":"39","author":"L\u00f6tscher F","year":"2019","unstructured":"L\u00f6tscher F, Krusche M, Ruffer N, Kubacki T, Person F, K\u00f6tter I. Cocaine-induced ANCA-associated renal disease: a case-based review. Rheumatol Int. 2019, 39:2005-14. 10.1007\/s00296-019-04410-9","journal-title":"Rheumatol Int"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.894537","article-title":"Is levamisole-induced vasculitis a relegated diagnostic possibility? A case report and review of literature","volume":"16","author":"Patnaik S","year":"2015","unstructured":"Patnaik S, Balderia P, Vanchhawng L, Markazi P, Wykretowicz J, Perloff S. Is levamisole-induced vasculitis a relegated diagnostic possibility? A case report and review of literature. Am J Case Rep. 2015, 16:658-62. 10.12659\/AJCR.894537","journal-title":"Am J Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14249","article-title":"Antineutrophil cytoplasmic antibodies negative levamisole-induced leukocytoclastic vasculitis: a presumed case and literature review","volume":"57","author":"Kunzler D","year":"2018","unstructured":"Kunzler D, Lagrimas L, Vo T, DeCrescenzo A, Kaltwasser K, Wilson J. Antineutrophil cytoplasmic antibodies negative levamisole-induced leukocytoclastic vasculitis: a presumed case and literature review. Int J Dermatol. 2018, 57:1411-6. 10.1111\/ijd.14249","journal-title":"Int J Dermatol"},{"key":"ref17","article-title":"Acute kidney injury and rhabdomyolysis after cocaine overdose: case report and literature review (Article in Italian)","volume":"35","author":"Mudoni A","year":"2018","unstructured":"Mudoni A, Caccetta F, Caroppo M, et al.. Acute kidney injury and rhabdomyolysis after cocaine overdose: case report and literature review (Article in Italian). G Ital Nefrol. 2018, 35:2018-vol2.","journal-title":"G Ital Nefrol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/20009666.2018.1536242","article-title":"Levamisole adulterated cocaine associated ANCA vasculitis: review of literature and update on pathogenesis","volume":"8","author":"Jin Q","year":"2018","unstructured":"Jin Q, Kant S, Alhariri J, Geetha D. Levamisole adulterated cocaine associated ANCA vasculitis: review of literature and update on pathogenesis. J Community Hosp Intern Med Perspect. 2018, 8:339-44. 10.1080\/20009666.2018.1536242","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.11124\/JBISRIR-D-19-00099","article-title":"Methodological quality of case series studies: an introduction to the JBI critical appraisal tool","volume":"18","author":"Munn Z","year":"2020","unstructured":"Munn Z, Barker TH, Moola S, et al.. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth. 2020, 18:2127-33. 10.11124\/JBISRIR-D-19-00099","journal-title":"JBI Evid Synth"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne JA","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, et al.. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016, 355:i4919. 10.1136\/bmj.i4919","journal-title":"BMJ"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt GH","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Sch\u00fcnemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008, 336:924-6. 10.1136\/bmj.39489.470347.AD","journal-title":"BMJ"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/402561-cocaine--and-levamisole-induced-vasculitis-cliv","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T11:31:30Z","timestamp":1758281490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/402561-cocaine--and-levamisole-induced-vasculitis-cliv"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.92701","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,9,19]]}}}